ORBIMED ADVISORS LLC Insider Trading $SUPN SUPERNUS PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is 10% Owner in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Loxo Oncology, Inc. ($LOXO).
ORBIMED ADVISORS LLC in SUPERNUS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner, Director
Holdings: 817,000 shares
Current Value: $20,139,050
Latest Transaction: Feb 14 2013
$SUPN Market Capitalization: $1.26B
$SUPN Previous Close: $24.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in SUPERNUS PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CCXI, ICPT, LOXO, RLYP, RPBIF, ROKA, SUPN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2013 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.58 | 41,100 | 311,361 | 817,000 | 858.1 K to 817 K (-4.79 %) |
| Feb 14 2013 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.58 | 108,900 | 824,994 | 2,183,000 | 2.3 M to 2.2 M (-4.75 %) |
| Feb 14 2013 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.52 | 41,483 | 312,027 | 858,100 | 899.6 K to 858.1 K (-4.61 %) |
| Feb 14 2013 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.52 | 110,700 | 832,663 | 2,291,900 | 2.4 M to 2.3 M (-4.61 %) |
| Dec 19 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 7.08 | 100,000 | 707,670 | 0 | 100 K to 0 (-100.00 %) |
| Dec 19 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 6.85 | 197,815 | 1,354,617 | 100,000 | 297.8 K to 100 K (-66.42 %) |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 827,627 | 0 | 0 | |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,498,842 | 0 | 0 | |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 6,673,891 | 0 | 0 | |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 90,999 | 454,995 | 297,815 | 206.8 K to 297.8 K (+44.00 %) |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 274,873 | 1,374,365 | 899,583 | 624.7 K to 899.6 K (+44.00 %) |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | P | 5.00 | 734,128 | 3,670,640 | 2,402,600 | 1.7 M to 2.4 M (+44.00 %) |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 206,816 | 0 | 206,816 | 0 to 206.8 K |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 624,710 | 0 | 624,710 | 0 to 624.7 K |
| May 08 2012 | SUPN | SUPERNUS PHARMACEU ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 1,668,472 | 0 | 1,668,472 | 0 to 1.7 M |
Page: 1